Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
2.030
-0.010 (-0.49%)
At close: Jun 6, 2025, 4:00 PM
2.150
+0.120 (5.91%)
After-hours: Jun 6, 2025, 7:37 PM EDT

Mangoceuticals Statistics

Total Valuation

Mangoceuticals has a market cap or net worth of $22.51 million. The enterprise value is $22.48 million.

Market Cap 22.51M
Enterprise Value 22.48M

Important Dates

The last earnings date was Thursday, May 15, 2025, after market close.

Earnings Date May 15, 2025
Ex-Dividend Date n/a

Share Statistics

Mangoceuticals has 11.03 million shares outstanding. The number of shares has increased by 113.52% in one year.

Current Share Class 11.03M
Shares Outstanding 11.03M
Shares Change (YoY) +113.52%
Shares Change (QoQ) +75.26%
Owned by Insiders (%) 9.80%
Owned by Institutions (%) 0.68%
Float 8.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.91
Forward PS n/a
PB Ratio 0.72
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 43.99
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.12, with a Debt / Equity ratio of 0.00.

Current Ratio 0.12
Quick Ratio 0.05
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -689.73

Financial Efficiency

Return on equity (ROE) is -115.89% and return on invested capital (ROIC) is -60.45%.

Return on Equity (ROE) -115.89%
Return on Assets (ROA) -53.55%
Return on Invested Capital (ROIC) -60.45%
Return on Capital Employed (ROCE) -46.66%
Revenue Per Employee $170,361
Profits Per Employee -$4.02M
Employee Count 3
Asset Turnover 0.05
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -65.87% in the last 52 weeks. The beta is 2.76, so Mangoceuticals's price volatility has been higher than the market average.

Beta (5Y) 2.76
52-Week Price Change -65.87%
50-Day Moving Average 1.89
200-Day Moving Average 2.91
Relative Strength Index (RSI) 52.44
Average Volume (20 Days) 204,658

Short Selling Information

The latest short interest is 127,026, so 1.15% of the outstanding shares have been sold short.

Short Interest 127,026
Short Previous Month 277,446
Short % of Shares Out 1.15%
Short % of Float 1.41%
Short Ratio (days to cover) 0.31

Income Statement

In the last 12 months, Mangoceuticals had revenue of $511,084 and -$12.05 million in losses. Loss per share was -$4.41.

Revenue 511,084
Gross Profit 294,630
Operating Income -9.45M
Pretax Income -9.02M
Net Income -12.05M
EBITDA -8.31M
EBIT -9.45M
Loss Per Share -$4.41
Full Income Statement

Balance Sheet

The company has $76,496 in cash and $47,713 in debt, giving a net cash position of $28,783 or $0.00 per share.

Cash & Cash Equivalents 76,496
Total Debt 47,713
Net Cash 28,783
Net Cash Per Share $0.00
Equity (Book Value) 20.25M
Book Value Per Share 2.83
Working Capital -1.33M
Full Balance Sheet

Cash Flow

Operating Cash Flow -6.15M
Capital Expenditures n/a
Free Cash Flow -6.15M
FCF Per Share -$0.56
Full Cash Flow Statement

Margins

Gross Margin 57.65%
Operating Margin -1,848.88%
Pretax Margin -2,187.33%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Mangoceuticals does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -113.52%
Shareholder Yield -113.52%
Earnings Yield -53.53%
FCF Yield -27.31%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 16, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Oct 16, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Mangoceuticals has an Altman Z-Score of 0.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.67
Piotroski F-Score 2